University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 21 of 23
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia
NCT00601224
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
NCT00494494
Evaluating a Web-Based Educational Program for Adults at Risk for Coronary Heart Disease (The Heart to Heart Feasibility Study)
NCT00494052
Improving Decision Making About Feeding Options for Dementia
NCT01113749
Maternal Oral Therapy to Reduce Obstetric Risk Kids
NCT03423836
Family Partners for Health
NCT01378806
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
NCT00614458
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
NCT00467532
Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements
NCT00466596
Oral Immunotherapy for Peanut Allergy (PMIT)
NCT00597675
Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure
NCT00378950
Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
NCT00617058
Intervention for Newly Diagnosed Youth With HIV
NCT00510237
Study of Dust Mite Inhalation in Humans
NCT00448851
C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention Interventions
NCT00271908
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
NCT00617240
Randomized Control Trial to Assess Postoperative Pain After Sling Placement
NCT00746863
The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet
NCT00766818
Mechanisms Underlying Drug-Diet Interactions
NCT01034124
The Effect of Yogurt Containing BB12 on Children's Health and Child Care Absenteeism
NCT00653705
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
NCT00609531
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732
Xylitol Adult Caries Trial (X-ACT)
NCT00393055
5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
NCT00450242
Brain Imaging of Psychotherapy for Depression
NCT00609453
Sex Differences in Early Brain Development; Brain Development in Turner Syndrome
NCT00877942
Mindfulness vs. Support Groups for Irritable Bowel Syndrome
NCT00680693
Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma
NCT00386178
Arthritis Self-Management Education Program
NCT00467064
Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis
NCT01028781
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
NCT00903955
Craniosacral Therapy in Migraine: A Feasibility Study
NCT00665236
Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents
NCT00450918
Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic
NCT00381043
Pharmacist-Administered Injections for Contraception
NCT00775047
Cigarette Smoke and Susceptibility to Influenza Infection
NCT00448617
C2P - Phase III: MPowerment and Community Promise
NCT00381784
Life Skills Intervention for Adolescents Perinatally Infected With HIV
NCT00272519
Study of Valproic Acid to Treat HIV Infected Adults
NCT00312546
Effect Of Obesity On Ozone-Induced Airway Inflammation
NCT00839943
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
NCT00318734
Rare Genetic Disorders of the Breathing Airways
NCT00323167
Immunotherapy for Peanut Allergy
NCT00429429
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
NCT00307216
Metabolic Abnormalities - HIV Infected and Uninfected Males
NCT00260936
PTSD and Risk Behavior in HIV Positive Female Adolescents
NCT00271882
Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab
NCT00287378
Intervention Development for Newly Diagnosed Youth With HIV
NCT00255892
PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir
NCT00273273
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
NCT00287365
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.